27.45
-0.22(-0.80%)
Currency In USD
| Previous Close | 27.67 |
| Open | 26.99 |
| Day High | 27.85 |
| Day Low | 25.85 |
| 52-Week High | 36.26 |
| 52-Week Low | 2.86 |
| Volume | 1.02M |
| Average Volume | 3.81M |
| Market Cap | 1.88B |
| PE | -15.6 |
| EPS | -1.76 |
| Moving Average 50 Days | 18.24 |
| Moving Average 200 Days | 8.67 |
| Change | -0.22 |
If you invested $1000 in Olema Pharmaceuticals, Inc. (OLMA) since IPO date, it would be worth $560.2 as of December 25, 2025 at a share price of $27.45. Whereas If you bought $1000 worth of Olema Pharmaceuticals, Inc. (OLMA) shares 3 years ago, it would be worth $10,680.93 as of December 25, 2025 at a share price of $27.45.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Olema Oncology to Participate in 8th Annual Evercore Healthcare Conference
GlobeNewswire Inc.
Nov 21, 2025 9:30 PM GMT
SAN FRANCISCO, Nov. 21, 2025 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema”, or “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies
Olema Oncology Announces Closing of $218.5 Million Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
GlobeNewswire Inc.
Nov 20, 2025 9:01 PM GMT
SAN FRANCISCO, Nov. 20, 2025 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies
Olema Oncology Announces Pricing of $190.0 Million Public Offering of Common Stock
GlobeNewswire Inc.
Nov 19, 2025 12:00 PM GMT
SAN FRANCISCO, Nov. 19, 2025 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies